Diclofenac epolamine is a topical anti-inflammatory pain reliever delivered through an adhesive patch applied directly to the skin. It combines diclofenac, one of the most widely used nonsteroidal anti-inflammatory drugs (NSAIDs), with a specific salt called epolamine that helps the medication absorb through skin more effectively than other forms of diclofenac. In the United States, it’s sold as the Flector Patch at a 1.3% concentration and is FDA-approved for treating acute pain from minor strains, sprains, and bruises.
Why the Epolamine Salt Matters
Diclofenac comes in several salt forms: sodium (used in most oral tablets), potassium, and epolamine. Each version pairs the same active drug with a different chemical partner, which changes how the medication behaves. Epolamine, chemically known as N-(2-hydroxyethyl)pyrrolidine, was specifically chosen for transdermal delivery because of two properties that make it unusually good at moving through skin.
First, the epolamine salt dissolves readily, which means more of the drug is available at the skin’s surface to begin absorbing. Second, the ring-shaped structure of the epolamine molecule helps diclofenac form larger, more fat-soluble pairings that can pass through the organized layers of skin tissue more efficiently. Researchers at the NIH have noted that this ring structure is likely “the determinant for a relevant permeation coefficient,” meaning it’s the key architectural feature that drives absorption. The epolamine salt also has a practical manufacturing advantage: it doesn’t form unstable crystal variations during production, which makes the final product more consistent and reliable.
How It Reduces Pain
Once diclofenac crosses the skin and reaches the underlying tissue, it works the same way as oral diclofenac. It blocks two enzymes, COX-1 and COX-2, that your body uses to produce compounds called prostanoids. These compounds, especially prostaglandin E2, are central players in inflammation and pain signaling. By cutting off their production at the injury site, diclofenac reduces swelling, tenderness, and pain locally.
Diclofenac inhibits COX-2 roughly four times more than COX-1 in lab settings. That’s relevant because COX-2 is the enzyme most responsible for inflammation, while COX-1 handles more routine functions like protecting the stomach lining. This preferential targeting is part of what makes diclofenac effective as a pain reliever, and applying it through a patch concentrates the drug in the tissue directly beneath the application site rather than flooding the entire bloodstream.
What the Patch Is Approved For
The FDA approved the Flector Patch specifically for acute pain from minor soft-tissue injuries: strains, sprains, and contusions (bruises). This means it’s intended for the kind of injuries that come from overexertion, awkward movements, or minor impacts, not for chronic conditions like arthritis or post-surgical pain. You apply one patch to the painful area and replace it every 12 hours, keeping the skin clean and dry between applications.
How Well It Works
In a study of 123 patients with acute back strain, the patch reduced average pain scores from 6.5 out of 10 at baseline to 2.5 by the end of treatment. Sixty-three percent of patients achieved at least a 50% reduction in pain. Patient satisfaction was high: 88% reported being satisfied or very satisfied, and 87% rated their overall pain relief as moderate to complete.
These results align with broader clinical guidelines. A 2022 multidisciplinary panel gave a strong recommendation (their highest grade) for topical NSAIDs as a treatment for acute musculoskeletal pain. The panel also concluded that topical NSAIDs are as effective as oral versions for acute pain but carry a better safety profile, and recommended topical formulations as the first-line choice for mild musculoskeletal pain.
Common Side Effects
The most frequent side effects are local skin reactions at the patch site. In clinical trials comparing the patch to a placebo patch, about 11% of patients using diclofenac epolamine reported skin-related issues, including itching (5%), dermatitis (2%), and less commonly, dryness, redness, or irritation. Interestingly, itching was actually more common in patients wearing the placebo patch (8%), suggesting that some skin irritation comes from the adhesive itself rather than the drug.
Gastrointestinal side effects occurred in about 9% of patch users, compared to 6% on placebo. Nausea was the most common at 3%, followed by an unusual taste in the mouth (2%) and indigestion (1%). While these rates are low, they do confirm that some diclofenac absorbs into the bloodstream even from a topical patch. Still, the GI side effects are considerably less frequent than what’s typically seen with oral diclofenac tablets, which is a major reason topical formulations exist.
How It Compares to Other Topical Pain Options
Diclofenac epolamine isn’t the only topical NSAID available. Diclofenac sodium comes in gel and solution forms for conditions like osteoarthritis, and other topical NSAIDs include ibuprofen, ketoprofen, and piroxicam formulations used in various countries. What distinguishes the epolamine patch is its delivery method: rather than rubbing in a gel multiple times a day, you apply a patch that provides continuous, controlled release over 12 hours. This can be more convenient and ensures consistent dosing to the area.
The patch format also means the drug stays where you put it. Gels can rub off on clothing or transfer to other people through skin contact. A patch stays in place and delivers its contents directly into the tissue underneath, which makes it particularly practical for areas like the upper back or shoulders where reapplying gel throughout the day would be difficult.